Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
head and neck cancer
Biotech
Bicara raises second $100M+ round of 2023, closing new series C
Bicara has raised a $165 million series C nine months after closing a similarly large $108 million series B round.
Max Bayer
Dec 12, 2023 6:30am
Merus shares dip as lung cancer data reveal 3 patient deaths
Dec 4, 2023 1:04pm
Adlai bags $57.5M IPO to test ex-Novartis cancer drug in phase 3
Sep 29, 2023 10:00am
FDA request extends CEL-SCI's multidecade Multikine journey
Jul 14, 2023 10:32am
J&J seizes on cash crunch to bag late-phase cancer candidate
Jul 10, 2023 5:30am
EpicentRx makes case for cancer toxicity prevention drug
Jan 20, 2023 9:50am